help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on August 8, 2008, doi:10.1164/rccm.200803-455OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200803-455OCv1
178/9/969    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wolk, K. E.
Right arrow Articles by Davis, I. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolk, K. E.
Right arrow Articles by Davis, I. C.
American Journal of Respiratory and Critical Care Medicine Vol 178. pp. 969-976, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200803-455OC


Original Article

Influenza A Virus Inhibits Alveolar Fluid Clearance in BALB/c Mice

Kendra E. Wolk1, Eduardo R. Lazarowski2, Zachary P. Traylor1, Erin N. Z. Yu1, Nancy A. Jewell3,4, Russell K. Durbin3, Joan E. Durbin3,4 and Ian C. Davis1

1 Department of Veterinary Biosciences, Ohio State University, Columbus, Ohio; 2 Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; 3 Columbus Children's Research Institute, Columbus, Ohio; and 4 Department of Pediatrics, Ohio State University, Columbus, Ohio

Correspondence and requests for reprints should be addressed to Ian C. Davis, D.V.M., Ph.D., Department of Veterinary Biosciences, Ohio State University, 331 Goss Lab, 1925 Coffey Road, Columbus, OH 43210. E-mail: davis.2448{at}osu.edu

Rationale: Pulmonary infections can impair alveolar fluid clearance (AFC), contributing to formation of lung edema. Effects of influenza A virus (IAV) on AFC are unknown.

Objectives: To determine effects of IAV infection on AFC, and to identify intercellular signaling mechanisms underlying influenza-mediated inhibition of AFC.

Methods: BALB/c mice were infected intranasally with influenza A/WSN/33 (10,000 or 2,500 focus-forming units per mouse). AFC was measured in anesthetized, ventilated mice by instilling 5% bovine serum albumin into the dependent lung.

Measurements and Main Results: Infection with high-dose IAV resulted in a steady decline in arterial oxygen saturation and increased lung water content. AFC was significantly inhibited starting 1 hour after infection, and remained suppressed through Day 6. AFC inhibition at early time points (1–4 h after infection) did not require viral replication, whereas AFC inhibition later in infection was replication-dependent. Low-dose IAV infection impaired AFC for 10 days, but induced only mild hypoxemia. High-dose IAV infection increased bronchoalveolar lavage fluid ATP and UTP levels. Impaired AFC at Day 2 resulted primarily from reduced amiloride-sensitive AFC, mediated by increased activation of the pyrimidine-P2Y purinergic receptor axis. However, an additional component of AFC impairment was due to activation of A1 adenosine receptors and stimulation of increased cystic fibrosis transmembrane regulator–mediated anion secretion. Finally, IAV-mediated inhibition of AFC at Day 2 could be reversed by addition of β-adrenergic agonists to the AFC instillate.

Conclusions: AFC inhibition may be an important feature of early IAV infection. Its blockade may reduce the severity of pulmonary edema and hypoxemia associated with influenza pneumonia.

Key Words: orthomyxovirus infections • pneumonia, viral • pulmonary edema • ion transport • adenosine


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Active transport of sodium ions by bronchoalveolar epithelial cells drives alveolar fluid clearance (AFC), which is crucial to efficient gas exchange in the lung.

What This Study Adds to the Field
Infection with influenza A virus has physiologically significant inhibitory effects on AFC in vivo in BALB/c mice, which result from uridine diphosphate–mediated inhibition of sodium transport and adenosine-mediated stimulation of chloride secretion.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  2009/2010 ATS Fellows Career Development Awards